Clinical Trial Update: The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pentoxifylline and vitamin E for radiotherapy-induced toxicity in head and neck cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Neoplasms

Drugs mentioned

• Pentoxifylline (pentoxifylline)
• Vitamin E (tocopherol)

Snippet

Sponsor: Ain Shams University | Conditions: Head and Neck Neoplasms | Phase 2 | Status: COMPLETED